Enterprise Value
90.47M
Cash
157M
Avg Qtr Burn
-16.14M
Short % of Float
8.97%
Insider Ownership
19.85%
Institutional Own.
46.56%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PYX-106 Details Colorectal cancer , Bladder cancer, Kidney cancer, Cholangiocarcinoma | Phase 1 Data readout | |
PYX-201 Details Breast cancer, Head and neck cancer, Lung cancer, Thyroid cancer | Phase 1 Data readout |